Acuta Capital Partners’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-6,000
| Closed | -$489K | – | 49 |
|
|
2020
Q4 | $489K | Sell |
6,000
-16,500
| -73% | -$1.34M | 0.13% | 48 |
|
|
2020
Q3 | $1.6M | Sell |
22,500
-67,500
| -75% | -$4.81M | 0.44% | 38 |
|
|
2020
Q2 | $7.41M | Sell |
90,000
-218,500
| -71% | -$18M | 2.14% | 18 |
|
|
2020
Q1 | $18.1M | Sell |
308,500
-299,000
| -49% | -$17.6M | 8.8% | 2 |
|
|
2019
Q4 | $62.8M | Buy |
607,500
+85,000
| +16% | +$8.79M | 15.55% | 1 |
|
|
2019
Q3 | $10.6M | Buy |
522,500
+85,000
| +19% | +$1.72M | 7.63% | 5 |
|
|
2019
Q2 | $11.3M | Buy |
+437,500
| New | +$11.3M | 4.01% | 8 |
|